Healthcare provider profile · identity verified

Stephen M Smith, M.D.

Family Practice · ESCANABA, MI · NPI 1477965127

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	746	200
Lisinopril	Lisinopril	621	166
Amlodipine Besylate	Amlodipine Besylate	611	160
Omeprazole	Omeprazole	419	127
Metoprolol Succinate	Metoprolol Succinate	414	119
Levothyroxine Sodium	Levothyroxine Sodium	373	107
Losartan Potassium	Losartan Potassium	360	107
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	339	54
Gabapentin	Gabapentin	287	68
Metformin Hcl	Metformin Hcl	270	81
Tamsulosin Hcl	Tamsulosin Hcl	246	79
Hydrochlorothiazide	Hydrochlorothiazide	245	71
Rosuvastatin Calcium	Rosuvastatin Calcium	245	77
Metoprolol Tartrate	Metoprolol Tartrate	236	63
Furosemide	Furosemide	235	65
Simvastatin	Simvastatin	229	63
Albuterol Sulfate Hfa	Albuterol Sulfate	199	63
Alprazolam	Alprazolam	188	42
Trazodone Hcl	Trazodone Hcl	170	51
Montelukast Sodium	Montelukast Sodium	166	50
Pravastatin Sodium	Pravastatin Sodium	164	38
Eliquis	Apixaban	158	37
Pantoprazole Sodium	Pantoprazole Sodium	157	50
Potassium Chloride	Potassium Chloride	149	45
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	133	20
Sertraline Hcl	Sertraline Hcl	125	36
Clopidogrel	Clopidogrel Bisulfate	116	38
Citalopram Hbr	Citalopram Hydrobromide	114	32
Tramadol Hcl	Tramadol Hcl	114	34
Fluticasone Propionate	Fluticasone Propionate	104	47
Fluoxetine Hcl	Fluoxetine Hcl	97	23
Escitalopram Oxalate	Escitalopram Oxalate	96	26
Spironolactone	Spironolactone	94	31
Venlafaxine Hcl Er	Venlafaxine Hcl	93	29
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	87	25
Meloxicam	Meloxicam	86	28
Clonazepam	Clonazepam	83	12
Duloxetine Hcl	Duloxetine Hcl	82	31
Xarelto	Rivaroxaban	82	24
Carvedilol	Carvedilol	79	22
Glipizide Er	Glipizide	79	22
Glipizide	Glipizide	78	19
Zolpidem Tartrate	Zolpidem Tartrate	77	18
Prednisone	Prednisone	76	47
Allopurinol	Allopurinol	75	23
Warfarin Sodium	Warfarin Sodium	73	16
Isosorbide Mononitrate Er	Isosorbide Mononitrate	72	17
Buspirone Hcl	Buspirone Hcl	67	24
Ezetimibe	Ezetimibe	67	19
Oxycodone Hcl	Oxycodone Hcl	66	suppressed
Jardiance	Empagliflozin	65	22
Donepezil Hcl	Donepezil Hcl	64	suppressed
Atenolol	Atenolol	62	15
Ozempic	Semaglutide	62	13
Lovastatin	Lovastatin	60	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	58	20
Wixela Inhub	Fluticasone Propion/Salmeterol	58	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	57	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	57	17
Nitroglycerin	Nitroglycerin	57	31
Alendronate Sodium	Alendronate Sodium	56	19
Famotidine	Famotidine	56	20
Esomeprazole Magnesium	Esomeprazole Magnesium	55	15
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	54	17
Bumetanide	Bumetanide	51	15
Metformin Hcl Er	Metformin Hcl	50	12
Pioglitazone Hcl	Pioglitazone Hcl	49	13
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	48	15
Mirtazapine	Mirtazapine	47	suppressed
Finasteride	Finasteride	46	14
Myrbetriq	Mirabegron	46	suppressed
Meclizine Hcl	Meclizine Hcl	45	13
Methylprednisolone	Methylprednisolone	45	30
Breo Ellipta	Fluticasone/Vilanterol	44	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	44	12
Ventolin Hfa	Albuterol Sulfate	44	16
Paroxetine Hcl	Paroxetine Hcl	43	15
Pregabalin	Pregabalin	41	13
Trulicity	Dulaglutide	41	suppressed
Tizanidine Hcl	Tizanidine Hcl	40	19
Hydroxyzine Hcl	Hydroxyzine Hcl	37	14
Diclofenac Sodium	Diclofenac Sodium	36	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	35	suppressed
Bupropion Xl	Bupropion Hcl	34	11
Terazosin Hcl	Terazosin Hcl	34	12
Valacyclovir	Valacyclovir Hcl	34	13
Enalapril Maleate	Enalapril Maleate	33	suppressed
Nystatin	Nystatin	33	16
Ondansetron Odt	Ondansetron	33	suppressed
Celecoxib	Celecoxib	32	suppressed
Ramipril	Ramipril	32	suppressed
Ropinirole Hcl	Ropinirole Hcl	32	suppressed
Mounjaro	Tirzepatide	31	suppressed
Naproxen	Naproxen	31	17
Estradiol	Estradiol	29	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	29	suppressed
Ondansetron Hcl	Ondansetron Hcl	29	15
Prazosin Hcl	Prazosin Hcl	29	suppressed
Telmisartan	Telmisartan	29	suppressed
Dutasteride	Dutasteride	28	suppressed
Januvia	Sitagliptin Phosphate	28	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	27	suppressed
Morphine Sulfate Er	Morphine Sulfate	27	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	27	17
Temazepam	Temazepam	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Hydralazine Hcl	Hydralazine Hcl	25	suppressed
Memantine Hcl	Memantine Hcl	25	suppressed
Benazepril Hcl	Benazepril Hcl	24	suppressed
Cephalexin	Cephalexin	24	19
Doxazosin Mesylate	Doxazosin Mesylate	24	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	24	22
Lansoprazole	Lansoprazole	23	suppressed
Repatha Sureclick	Evolocumab	23	suppressed
Symbicort	Budesonide/Formoterol Fumarate	23	suppressed
Propranolol Hcl Er	Propranolol Hcl	21	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	20	suppressed
Digoxin	Digoxin	20	suppressed
Valsartan	Valsartan	20	suppressed
Aripiprazole	Aripiprazole	19	suppressed
Methocarbamol	Methocarbamol	19	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Amiodarone Hcl	Amiodarone Hcl	17	suppressed
Carbamazepine	Carbamazepine	17	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Synthroid	Levothyroxine Sodium	17	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	16	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	15	suppressed
Azelastine Hcl	Azelastine Hcl	15	suppressed
Fluconazole	Fluconazole	15	suppressed
Primidone	Primidone	15	suppressed
Verapamil Er	Verapamil Hcl	15	suppressed
Brilinta	Ticagrelor	14	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	14	suppressed
Labetalol Hcl	Labetalol Hcl	14	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	13
Baclofen	Baclofen	13	suppressed
Fentanyl	Fentanyl	13	suppressed
Jantoven	Warfarin Sodium	13	suppressed
Memantine Hcl Er	Memantine Hcl	13	suppressed
Mesalamine	Mesalamine	13	suppressed
Nabumetone	Nabumetone	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	12	suppressed
Guanfacine Hcl Er	Guanfacine Hcl	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Loperamide	Loperamide Hcl	12	suppressed
Risperidone	Risperidone	12	suppressed
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Azithromycin	Azithromycin	11	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	11	suppressed
Tiotropium Bromide	Tiotropium Bromide	11	suppressed
Torsemide	Torsemide	11	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	11	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error